The Archive · A Source

First Patient Dosed in Beckley Psytech's Phase IIb BPL-003 Study

Business Wire October 2023 www.businesswire.com/news/home/20231024634081/en/First-Patient-Dosed-in-Beckley-Psytechs-International-Phase-IIb-Study-of-BPL-003-a-Novel-Synthetic-Intranasal-Formulation-of-5-MeO-DMT-for-Treatment-Resistant-Depression-TRD